IHR: High Resolution Retina Imaging

Sponsor
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts (Other)
Overall Status
Recruiting
CT.gov ID
NCT04128150
Collaborator
(none)
1,000
3
72.4
333.3
4.6

Study Details

Study Description

Brief Summary

To increase the clinical experience of using the rtx1 camera in various retinal disorders and to follow the evolution of structural alterations during retinal diseases using adaptive optics imaging with the rtx1 camera

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
1000 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
High Resolution Retina Imaging
Actual Study Start Date :
Jan 17, 2018
Anticipated Primary Completion Date :
Jan 30, 2023
Anticipated Study Completion Date :
Jan 30, 2024

Outcome Measures

Primary Outcome Measures

  1. Evolution of retina diseases [From date of inclusion until the date of last documented progression , assessed up to 5 years]

    Increase the clinical experience of using the rtx1 camera in various conditions with retinal impact

Eligibility Criteria

Criteria

Ages Eligible for Study:
12 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Persons over 12 years of age, of both sexes, presenting with retinal pathologies.

  • Beneficiaries of the health insurance

Exclusion Criteria:
  • Any abnormality preventing good quality OA imaging on both eyes

  • Major under guardianship or curatorship

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hôpital Lariboisière Paris France 75010
2 Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts Paris France 75012
3 Hôpital Pitié-Salpétrière Paris France 75013

Sponsors and Collaborators

  • Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts

Investigators

  • Principal Investigator: Michel PAQUES, Centre Hospitalier National d'Ophtalmologie des Quinze-Vints

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
ClinicalTrials.gov Identifier:
NCT04128150
Other Study ID Numbers:
  • 2017-A03223-50
  • 2017-A03223-50
First Posted:
Oct 16, 2019
Last Update Posted:
Oct 16, 2019
Last Verified:
Oct 1, 2019
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 16, 2019